Skip to main content
OpenTrials

Clinical trial condition

Gastrointestinal Neoplasms

Explore clinical trials studying Gastrointestinal Neoplasms. Study availability and eligibility vary by location and protocol.

9,148 public trials 2,022 recruiting studies
Refine in advanced search Browse all conditions

Gastrointestinal Neoplasms trial results

Active, Not Recruiting

GEMCAD-REVEAL STUDY - Circulating Tumor DNA as a Predictor of Relapse in Patients With Locally Advanced Rectal Cancer.

NCT05674422

Conditions
Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations
  • Hospital Germans Trias i Pujol - ICO Badalona Badalona, Barcelona, Spain
  • Hospital Universitari Mutua de Terrassa Terrassa, Barcelona, Spain
  • Hospital Universitario 12 de Octubre Madrid, Spain
  • H. de la Santa Creu i Sant Pau Barcelona, Spain
View all 15 locations
View Trial Details
Active, Not Recruiting

First in Human Study of TORL-2-307-MAB in Participants With Advanced Cancer

NCT05159440

Conditions
Advanced Solid Tumor, Digestive System Diseases, Digestive System Neoplasms, +13 more
Locations
  • Providence St. Jude Medical Center Fullerton, California, United States
  • UCLA - JCCC Clinical Research Unit Los Angeles, California, United States
  • Torrance Memorial Medical Torrance, California, United States
  • Fort Wayne Medical Oncology and Hematology Fort Wayne, Indiana, United States
View Trial Details
Active, Not Recruiting

A Study of MRG002 in Patients with HER2-Positive Advanced Solid Tumors and Locally Advanced or Metastatic Gastric/Gastroesophageal Junction (GEJ) Cancer

NCT04492488

Conditions
Advanced Solid Tumors, Advanced or Metastatic Gastric Cancer, Advanced or Metastatic Gastroesophageal Junction Cancer, +8 more
Locations
  • University of California Irvine Chao Family Comprehensive Cancer Center Orange, California, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Active, Not Recruiting

Study to Evaluate the Efficacy of FOLFOX + Panitumumab Followed by FOLFIRI + Bevacizumab (Sequence 1) Versus FOLFOX + Bevacizumab Followed by FOLFIRI + Panitumumab (Sequence 2) in Untreated Patients With Wild-type RAS Metastatic, Primary Left-sided, Unresectable Colorectal Cancer

NCT03635021

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations
  • Spanish Cooperative Group for the Treatment of Digestive Tumors Madrid, Spain
View Trial Details

Related conditions